| First Author | Gonçalves R | Year | 2023 |
| Journal | iScience | Volume | 26 |
| Issue | 2 | Pages | 105972 |
| PubMed ID | 36687317 | Mgi Jnum | J:348327 |
| Mgi Id | MGI:7430480 | Doi | 10.1016/j.isci.2023.105972 |
| Citation | Goncalves R, et al. (2023) SARS-CoV-2 variants induce distinct disease and impact in the bone marrow and thymus of mice. iScience 26(2):105972 |
| abstractText | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved to variants associated with milder disease. We employed the k18-hACE2 mouse model to study how differences in the course of infection by SARS-CoV-2 variants alpha, delta, and omicron relate to tissue pathology and the immune response triggered. We documented a variant-specific pattern of infection severity, inducing discrete lung and blood immune responses and differentially impacting primary lymphoid organs. Infections with variants alpha and delta promoted bone marrow (BM) emergency myelopoiesis, with blood and lung neutrophilia. The defects in the BM hematopoietic compartment extended to the thymus, with the infection by the alpha variant provoking a marked thymic atrophy. Importantly, the changes in the immune responses correlated with the severity of infection. Our study provides a comprehensive platform to investigate the modulation of disease by SARS-CoV-2 variants and underscores the impact of this infection on the function of primary lymphoid organs. |
